Published in Gut on June 01, 1991
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut (2001) 1.62
Patients with irritable bowel syndrome exhale more hydrogen than healthy subjects in fasting state. J Neurogastroenterol Motil (2010) 1.07
Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air? Gastroenterol Hepatol (N Y) (2011) 0.91
Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome. Gut (2001) 0.89
The irritable bowel syndrome. Postgrad Med J (1997) 0.87
Aerophagia and Intestinal Gas. Curr Treat Options Gastroenterol (2002) 0.86
Abdominal bloating: pathophysiology and treatment. J Neurogastroenterol Motil (2013) 0.83
From comic relief to real understanding; how intestinal gas causes symptoms. Gut (2003) 0.82
Expert commentary--bloating, distension, and the irritable bowel syndrome. MedGenMed (2005) 0.81
Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome. Dig Dis Sci (2011) 0.81
Bloating and functional gastro-intestinal disorders: where are we and where are we going? World J Gastroenterol (2014) 0.80
Functional abdominal bloating with distention. ISRN Gastroenterol (2012) 0.78
Relationship of bloating to other GI and menstrual symptoms in women with irritable bowel syndrome. Dig Dis Sci (2004) 0.78
Computed tomography assessment of intestinal gas volumes in functional gastrointestinal disorders. J Neurogastroenterol Motil (2012) 0.77
Intestinal gas dynamics: mechanisms and clinical relevance. Gut (2005) 0.77
Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. Am J Physiol Gastrointest Liver Physiol (2015) 0.76
Gas and Bloating. Gastroenterol Hepatol (N Y) (2006) 0.75
Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge. Am J Gastroenterol (2017) 0.75
Towards positive diagnosis of the irritable bowel. Br Med J (1978) 12.79
Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology (1987) 2.80
Twenty four hour manometric recording of colonic motor activity in healthy man. Gut (1987) 2.75
The irritable bowel syndrome: a paroxysmal motor disorder. Lancet (1985) 1.99
Ranking of symptoms by patients with the irritable bowel syndrome. BMJ (1989) 1.87
The role of intestinal gas in functional abdominal pain. N Engl J Med (1975) 1.85
Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease. Gut (1984) 1.64
Diurnal changes in myoelectric spiking activity of the human colon. Gastroenterology (1985) 1.40
Sigmoid motility in diverticular disease and the irritable bowel syndrome. Gut (1988) 1.34
Fasting and postprandial myoelectric spiking activity in the human sigmoid colon. Gastroenterology (1983) 0.94
The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell (1985) 7.16
The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther (1997) 5.78
Non-colonic features of irritable bowel syndrome. Gut (1986) 5.48
Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population. J Med Microbiol (1986) 4.95
Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature (1991) 4.77
Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet (1984) 4.11
Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. N Engl J Med (1990) 3.63
Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut (2004) 3.55
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther (2003) 3.41
Is chest pain after sumatriptan oesophageal in origin? Lancet (1994) 3.34
Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet (1981) 2.95
Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther (2015) 2.90
Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature (1987) 2.89
Bran and irritable bowel syndrome: time for reappraisal. Lancet (1994) 2.68
Cat scratch disease: posterior segment manifestations. Ophthalmology (1999) 2.67
Ultrasound training for non-radiologists. Clin Radiol (1995) 2.58
Endoscopic management of common duct stones without cholecystectomy. Br J Surg (1987) 2.56
Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ (2009) 2.51
The natural history of dysphagia following a stroke. Dysphagia (1997) 2.51
The molecular genetics of Marfan syndrome and related disorders. J Med Genet (2006) 2.45
Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut (1983) 2.39
In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet (2003) 2.26
Isolation of reovirus-like agents from patients with Crohn's disease. Lancet (1977) 2.24
Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol (1999) 2.24
Irritable bowel syndrome, chronic pelvic inflammatory disease and endometriosis: a comparison of symptomatology. Eur J Gastroenterol Hepatol (2004) 2.20
Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology (1993) 2.10
Glycine to serine substitution in the triple helical domain of pro-alpha 1 (II) collagen results in a lethal perinatal form of short-limbed dwarfism. J Biol Chem (1989) 2.09
The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet (2000) 2.01
Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. N Engl J Med (1992) 1.95
Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut (1997) 1.88
Ranking of symptoms by patients with the irritable bowel syndrome. BMJ (1989) 1.87
Bottle feeding, early gastroenteritis, and inflammatory bowel disease. Br Med J (1979) 1.83
Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.82
Ultrasound for gastroenterologists. Gut (1996) 1.82
Tegaserod for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev (2004) 1.81
Hypnotherapy in severe irritable bowel syndrome: further experience. Gut (1987) 1.79
Structure and expression of the human and mouse T4 genes. Proc Natl Acad Sci U S A (1987) 1.77
Review article: abdominal bloating and distension in functional gastrointestinal disorders--epidemiology and exploration of possible mechanisms. Aliment Pharmacol Ther (2007) 1.71
Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects. Gut (1990) 1.70
Diagnostic criteria for irritable bowel syndrome: utility and applicability in clinical practice. Digestion (2004) 1.69
Gastrostomy insertion: comparing the options--PEG, RIG or PIG? Clin Radiol (2003) 1.67
Effects of toxin of red tide, Ptychodiscus brevis, on canine tracheal smooth muscle: a possible new asthma-triggering mechanism. J Allergy Clin Immunol (1982) 1.64
Long term benefits of hypnotherapy for irritable bowel syndrome. Gut (2003) 1.63
Oesophageal motility in the irritable bowel syndrome. Br Med J (Clin Res Ed) (1981) 1.63
Crohn's disease in a husband and wife. Lancet (1978) 1.61
A single-blind crossover comparison of fenoprofen, ibuprofen and naproxen in rheumatoid arthritis. Curr Med Res Opin (1974) 1.60
Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut (2003) 1.58
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther (2008) 1.57
Macular hole surgery using thrombin-activated fibrinogen and selective removal of the internal limiting membrane. Retina (1998) 1.52
Are complications of endoscopic sphincterotomy age related? Gut (1997) 1.51
Endoscopic management of Mirizzi's syndrome. Gut (1997) 1.50
Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut (2007) 1.50
Management of endophthalmitis in the post-endophthalmitis vitrectomy study era. Arch Ophthalmol (2001) 1.49
'Nodular necrobiosis': a new cutaneous manifestation of Crohn's disease? Gut (1982) 1.49
Patterns, incidence and predictive factors for pain after interventional radiology. Clin Radiol (2005) 1.45
Clinical economics review: irritable bowel syndrome. Aliment Pharmacol Ther (1997) 1.43
Bladder smooth muscle dysfunction in patients with irritable bowel syndrome. Gut (1986) 1.41
Conscious sedation for endoscopic and non-endoscopic interventional gastrointestinal procedures: meeting patients' expectations, missing the standard. Clin Radiol (2004) 1.41
What do patients with irritable bowel syndrome dream about? A comparison with inflammatory bowel disease. Dig Liver Dis (2002) 1.39
The use of effervescent agents in the small bowel meal examination. Clin Radiol (1993) 1.39
The influence of type of tube and experience of the operator on performance of small bowel enema. Br J Radiol (1989) 1.39
The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut (2002) 1.39
Arterial blood gas tensions during upper gastrointestinal endoscopy. Gut (1976) 1.39
A pilot exploratory study of oral electrical stimulation on swallow function following stroke: an innovative technique. Dysphagia (1997) 1.39
Endoscopic sphincterotomy: the whole truth. Br J Surg (1991) 1.37
P1148A in fibrillin-1 is not a mutation anymore. Nat Genet (1997) 1.37
More accurate diagnosis of irritable bowel syndrome by the use of 'non-colonic' symptomatology. Gut (1991) 1.37
Pulmonary function in patients with inflammatory bowel disease. Am J Gastroenterol (1980) 1.36
Can bedside assessment reliably exclude aspiration following acute stroke? Age Ageing (1998) 1.36
Double blind study of ispaghula in irritable bowel syndrome. Gut (1987) 1.35
Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology (1996) 1.35
Risks of leaving the gallbladder in situ after endoscopic sphincterotomy for bile duct stones. Br J Surg (1991) 1.32
Irritable bowel syndrome: diagnosis and management. BMJ (2006) 1.31
Antibodies to Campylobacter pyloridis in household contacts of infected patients. Br Med J (Clin Res Ed) (1987) 1.28
Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group. N Engl J Med (1997) 1.27
Symptomatology, quality of life and economic features of irritable bowel syndrome--the effect of hypnotherapy. Aliment Pharmacol Ther (1996) 1.26
Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. Gut (2006) 1.26
Design of treatment trials for functional gastrointestinal disorders. Gut (1999) 1.23
Endoscopic removal of retained stones after biliary surgery. Br J Surg (1988) 1.22
Severe sexual dysfunction in women with the irritable bowel syndrome: comparison with inflammatory bowel disease and duodenal ulceration. Br Med J (Clin Res Ed) (1987) 1.22
Proteus infections in a general hospital. II. Some clinical and epidemiological characteristis. With an analysis of 71 cases of proteus bacteremia. Ann Intern Med (1971) 1.21
Etiologic factors associated with anterior knee pain in distance runners. Med Sci Sports Exerc (2000) 1.21
Death from ischaemic heart-disease and malignancy in adult patients with coeliac disease. Lancet (1976) 1.19
Age and ovariectomy impair both the normalization of mechanical properties and the accretion of mineral by the fracture callus in rats. J Orthop Res (2001) 1.17
Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40. Eur J Hum Genet (2001) 1.17
Muscle thickness, measured with ultrasound, may be an indicator of lean tissue wasting in multiple organ failure in the presence of edema. Am J Clin Nutr (1995) 1.16
Novel exon skipping mutation in the fibrillin-1 gene: two 'hot spots' for the neonatal Marfan syndrome. Clin Genet (1999) 1.15
Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2. Am J Hum Genet (1996) 1.14
Quality of life in irritable bowel syndrome. Pharmacoeconomics (2001) 1.14
Gastric mucosal lymphocyte subpopulations in pernicious anemia and in normal stomach. Clin Immunol Immunopathol (1983) 1.14
Irritable bowel syndrome in the gynecological clinic. Survey of 798 new referrals. Dig Dis Sci (1989) 1.14
Ulcerative colitis in association with Takayasu's disease. Am J Dig Dis (1978) 1.13
Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens (1999) 1.13
Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility. Neurogastroenterol Motil (2005) 1.13
Antibodies to maize in patients with Crohn's disease, ulcerative colitis and coeliac disease. Clin Exp Immunol (1979) 1.11
Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal Marfan syndrome. Hum Mol Genet (1995) 1.11
Isolation and characterization of a toxin from the Florida red tide organism. Nature (1969) 1.10
Crohn's disease in husband and wife. Lancet (1981) 1.10